Marc Thibonnier

4.0k total citations
92 papers, 3.2k citations indexed

About

Marc Thibonnier is a scholar working on Social Psychology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Thibonnier has authored 92 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Social Psychology, 37 papers in Molecular Biology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Thibonnier's work include Neuroendocrine regulation and behavior (42 papers), Electrolyte and hormonal disorders (30 papers) and Receptor Mechanisms and Signaling (17 papers). Marc Thibonnier is often cited by papers focused on Neuroendocrine regulation and behavior (42 papers), Electrolyte and hormonal disorders (30 papers) and Receptor Mechanisms and Signaling (17 papers). Marc Thibonnier collaborates with scholars based in United States, France and Singapore. Marc Thibonnier's co-authors include Liliana N. Berti‐Mattera, Pamela L. Wilkins, Éric Clauser, Colette Auzan, Menachem Shoham, Terry Taylor, Marc Gittelman, Harin Padma-Nathan, Wayne J.G. Hellstrom and Thomas P. Segerson and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Marc Thibonnier

90 papers receiving 3.1k citations

Peers

Marc Thibonnier

PRM

EDM

EAS

A.M. Naylor United Kingdom

Heinz Valtin United States

Nancy L. Ostrowski United States

Dieter Rosskopf Germany

Alfredo Costa Italy

Walter B. Severs United States

Harold E. Carlson United States

Jack M. George United States

Frederick A.O. Mendelsohn Australia

Dolores Prieto Spain

A.M. Naylor United Kingdom

Marc Thibonnier

390 ×0.3

523 ×0.5

148 ×0.2

PRM

593 ×1.0

EDM

299 ×0.5

EAS

Citations per year, relative to Marc Thibonnier Marc Thibonnier (= 1×) peers A.M. Naylor

Countries citing papers authored by Marc Thibonnier

Since Specialization

Citations

This map shows the geographic impact of Marc Thibonnier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Thibonnier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Thibonnier more than expected).

Fields of papers citing papers by Marc Thibonnier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Thibonnier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Thibonnier. The network helps show where Marc Thibonnier may publish in the future.

Co-authorship network of co-authors of Marc Thibonnier

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Thibonnier. A scholar is included among the top collaborators of Marc Thibonnier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Thibonnier. Marc Thibonnier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thibonnier, Marc & Sujoy Ghosh. (2023). Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs. International Journal of Molecular Sciences. 24(8). 7126–7126. 6 indexed citations

Thibonnier, Marc, Sujoy Ghosh, & Anne Blanchard. (2021). Effects of a short‐term cold exposure on circulating microRNAs and metabolic parameters in healthy adult subjects. Journal of Cellular and Molecular Medicine. 26(2). 548–562. 4 indexed citations

Thibonnier, Marc, Christine Esau, Sujoy Ghosh, Edward T. Wargent, & Claire J. Stocker. (2020). Metabolic and energetic benefits of microRNA-22 inhibition. BMJ Open Diabetes Research & Care. 8(1). e001478–e001478. 30 indexed citations

Jing, Zhifeng, Rui Qi, Marc Thibonnier, & Pengyu Ren. (2019). Molecular Dynamics Study of the Hybridization between RNA and Modified Oligonucleotides. Journal of Chemical Theory and Computation. 15(11). 6422–6432. 19 indexed citations

Thibonnier, Marc & Christine Esau. (2019). Metabolic Benefits of MicroRNA-22 Inhibition. Nucleic Acid Therapeutics. 30(2). 104–116. 21 indexed citations

Wu, Nan, Susan M. Hanson, Derek J. Francis, et al.. (2006). Arrestin Binding to Calmodulin: A Direct Interaction Between Two Ubiquitous Signaling Proteins. Journal of Molecular Biology. 364(5). 955–963. 70 indexed citations

Wu, Nan, Stanley Nithianantham, Susan M. Hanson, et al.. (2006). Soluble Mimics of the Cytoplasmic Face of the Human V1-Vascular Vasopressin Receptor Bind Arrestin2 and Calmodulin. Molecular Pharmacology. 70(1). 249–258. 6 indexed citations

Mahmood, Syed, Stanley Nithianantham, Zhen Xu, et al.. (2005). A C-terminal segment of the V₁R vasopressin receptor is unstructured in the crystal structure of its chimera with the maltose-binding protein. Acta Crystallographica Section F Structural Biology and Crystallization Communications. 61(4). 341–345. 8 indexed citations

Montorsi, Francesco, Wayne J.G. Hellstrom, Luc Valiquette, et al.. (2004). Vardenafil provides reliable efficacy over time in men with erectile dysfunction. Urology. 64(6). 1187–1195. 25 indexed citations

10.

Thibonnier, Marc. (2003). Vasopressin receptor antagonists in heart failure. Current Opinion in Pharmacology. 3(6). 683–687. 30 indexed citations

11.

Hellstrom, Wayne J.G., Marc Gittelman, Gary Karlin, et al.. (2003). Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial. Urology. 61(4). 8–14. 114 indexed citations

12.

Thibonnier, Marc, et al.. (2002). Chapter 14 Molecular pharmacology and modeling of vasopressin receptors. Progress in brain research. 139. 179–196. 79 indexed citations

13.

Thibonnier, Marc, et al.. (2001). Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists. Expert Opinion on Investigational Drugs. 10(5). 825–834. 14 indexed citations

14.

Thibonnier, Marc, et al.. (1999). Human Vascular Endothelial Cells Express Oxytocin Receptors*. Endocrinology. 140(3). 1301–1309. 209 indexed citations

15.

Thibonnier, Marc. (1998). Development and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists. Expert Opinion on Investigational Drugs. 7(5). 729–740. 18 indexed citations

16.

Thibonnier, Marc, et al.. (1996). Structure, Sequence, Expression, and Chromosomal Localization of the Human V1aVasopressin Receptor Gene. Genomics. 31(3). 327–334. 65 indexed citations

17.

Keyzer, Yves de, Colette Auzan, Frédéric Lenne, et al.. (1994). Cloning and characterization of the human V3 pituitary vasopressin receptor. FEBS Letters. 356(2-3). 215–220. 161 indexed citations

18.

Thibonnier, Marc. (1992). Signal transduction of V1-vascular vasopressin receptors. Regulatory Peptides. 38(1). 1–11. 116 indexed citations

19.

Pagny, Jean-Yves, Marc Thibonnier, Pierre Corvol, & Joël Ménard. (1985). Acute inhibition of the renin-angiotensin system: interest and limits to detect surgically curable hypertension.. PubMed. 7 Suppl 4. S82–5. 2 indexed citations

20.

Reach, G., et al.. (1980). Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.. BMJ. 280(6227). 1300.2–1301. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact